Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanting Ouyang

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Therapeutic Advances in Medical Oncology|March 30, 2026
Updated cost comparison of home care subcutaneous versus outpatient intravenous trastuzumab for HER2-positive breast cancer in SingaporeYanting Ouyang, Yi Ting Ng, Wei Wei Hong, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 16, 2026
The Early Cost-Effectiveness of a Novel Scalp Cooling Device to Alleviate Chemotherapy-Induced Alopecia in Patients with Early Breast CancerYanting Ouyang, Yiying Cai, Eileen Yi Ling Poon, et al.
Value in Health Regional Issues|March 25, 2026
Economic Cost of Knee Osteoarthritis in SingaporeYanting Ouyang, Julian Lim, Bryan Tan, et al.
Therapeutic Advances in Medical Oncology|November 12, 2024
Cost-minimization analysis comparing subcutaneous trastuzumab at home with intravenous trastuzumab for HER2-positive breast cancer in SingaporeYanting Ouyang, Han Yi Lee, Fun Loon Leong, et al.
Plos One|January 16, 2026
Drug-loaded nanoparticles for intra-articular injectionPiaopiao Pan, Konstantina Simou, Yanting Ouyang, et al.
International Journal of Pharmaceutics|January 10, 2023
Supercritical fluid coating of flavonoids on excipients enhances drug release and antioxidant activityHongling He, Yating Huang, Xiubing Zhang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Medical Oncology|March 30, 2026
Updated cost comparison of home care subcutaneous versus outpatient intravenous trastuzumab for HER2-positive breast cancer in SingaporeYanting Ouyang, Yi Ting Ng, Wei Wei Hong, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 16, 2026
The Early Cost-Effectiveness of a Novel Scalp Cooling Device to Alleviate Chemotherapy-Induced Alopecia in Patients with Early Breast CancerYanting Ouyang, Yiying Cai, Eileen Yi Ling Poon, et al.
Value in Health Regional Issues|March 25, 2026
Economic Cost of Knee Osteoarthritis in SingaporeYanting Ouyang, Julian Lim, Bryan Tan, et al.
Therapeutic Advances in Medical Oncology|November 12, 2024
Cost-minimization analysis comparing subcutaneous trastuzumab at home with intravenous trastuzumab for HER2-positive breast cancer in SingaporeYanting Ouyang, Han Yi Lee, Fun Loon Leong, et al.
Plos One|January 16, 2026
Drug-loaded nanoparticles for intra-articular injectionPiaopiao Pan, Konstantina Simou, Yanting Ouyang, et al.
International Journal of Pharmaceutics|January 10, 2023
Supercritical fluid coating of flavonoids on excipients enhances drug release and antioxidant activityHongling He, Yating Huang, Xiubing Zhang, et al.
Pageof 1